Tumor necrosis factor-α and vascular angiotensin II in estrogen-deficient rats

Hypertension

Volumn 48, Issue 3, 2006, Pages 497-503

  Arenas, Ivan A ^a   Armstrong, Stephen J ^a   Xu, Yi ^a   Davidge, Sandra T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aging; Angiotensin II; Estrogen; Tumor necrosis factor; Vasoconstriction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN; ETANERCEPT; PHENYLEPHRINE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; IMMUNOFLUORESCENCE; MENOPAUSE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VASCULAR DISEASE; VASOCONSTRICTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; ENDOTHELIUM, VASCULAR; ESTROGENS; FEMALE; IMMUNOGLOBULIN G; MESENTERIC ARTERIES; PEPTIDYL-DIPEPTIDASE A; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, TUMOR NECROSIS FACTOR; TETRAZOLES; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33747391949     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000235865.03528.f1     Document Type: Article

References (54)

1. Proudler AJ, Ahmed AI, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet. 1995;346:89-90.
2. Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, Stablein A, Beckers F, Smits JF, Daemen MJ, Vetter H, Bohm M. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation. 1998;97:2197-2201.
3. Harrison-Bernard LM. Targeting of the renin-Angiotensin system as an adjunct to estrogen replacement therapy. Hypertension. 2004;44:390-391.
4. Hinojosa-Laborde C, Craig T, Zheng W, Ji H, Haywood JR, Sandberg K. Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension. 2004;44:405-409.
5. Harrison-Bernard LM, Schulman IH, Raij L. Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity. Hypertension. 2003;42:1157-1163.
6. Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension. 2004;43:918-923.
7. Muller DN, Luft FC. The renin-angiotensin system in the vessel wall. Basic Res Cardiol. 1998;93(suppl 2):7-14.
8. Oliver JA, Sciacca RR. Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest. 1984;74:1247-1251.
9. Malik KU, Nasjletti A. Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ Res. 1976;38:26-30.
10. Qiu HY, Henrion D, Levy BI. Endogenous angiotensin II enhances phenylephrine-induced tone in hypertensive rats. Hypertension. 1994;24:317-321.
11. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension. 2001;38:1382-1387.
12. Ferrari R. The role of TNF in cardiovascular disease. Pharmacol Res. 1999;40:97-105.
13. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19:149-154.
14. Arenas IA, Armstrong SJ, Xu Y, Davidge ST. Chronic tumor necrosis factor-{alpha} inhibition enhances NO modulation of vascular function in estrogen-deficient rats. Hypertension. 2005;46:76-81.
15. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.
16. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296:1634-1635.
17. Jamaluddin M, Meng T, Sun J, Boldogh I, Han Y, Brasier AR. Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation. Mol Endocrinol. 2000;14:99-113.
18. Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol Cell Physiol. 2004;286:C779-C784.
19. Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension. 1996;27:1009-1017.
20. Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension. 1997;30:35-41.
21. Armstrong SJ, Zhang Y, Stewart KG, Davidge ST. Estrogen replacement reduces PGHS-2-dependent vasoconstriction in the aged rat. Am J Physiol Heart Circ Physiol. 2002;283:H893-H898.
22. Armstrong SJ, Xu Y, Davidge ST. Effects of chronic PGHS-2 inhibition on PGHS-dependent vasoconstriction in the aged female rat. Cardiovasc Res. 2004;61:333-338.
23. Hemmings DG, Xu Y, Davidge ST. Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. Br J Pharmacol. 2004;143:276-284.
24. Xu Y, Arenas IA, Armstrong SJ, Davidge ST. Estrogen modulation of left ventricular remodeling in the aged heart. Cardiovasc Res. 2003;57:388-394.
25. Zhang Y, Stewart KG, Davidge ST. Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries. Hypertension. 2000;36:970-974.
26. Korth-Bradley JM, Rubin AS, Hanna RK, Simcoe DK, Lebsack ME. The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother. 2000;34:161-164.
27. Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J Cardiovasc Pharmacol. 2001;38:141-148.
28. Collis MG, Keddie JR. Captopril attenuates adrenergic vasoconstriction in rat mesenteric arteries by angiotensin-dependent and -independent mechanisms. Clin Sci (Lond). 1981;61:281-286.
29. Kamada M, Irahara M, Maegawa M, Ohmoto Y, Takeji T, Yasui T, Aono T. Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol. 2001;184:309-314.
30. Sites CK, Toth MJ, Cushman M, L'Hommedieu GD, Tchernof A, Tracy RP, Poehlman ET. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril. 2002;77:128-135.
31. Davidge ST, Zhang Y. Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries. Circ Res. 1998;83:388-395.
32. Minami N, Mori N, Nagasaka M, Kurosawa H, Kanazawa M, Kohzuki M. Effect of estrogen on pressor responses to alpha1-adrenoreceptor agonist in conscious female rats. Hypertens Res. 2002;25:609-613.
33. Vongpatanasin W, Tuncel M, Mansour Y, Arbique D, Victor RG. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation. 2001;103:2903-2908.
34. Maeso R, Navarro-Cid J, Munoz-Garcia R, Rodrigo E, Ruilope LM, Lahera V, Cachofeiro V. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors. Hypertension. 1996;28:967-972.
35. Ziogas J, Story DF. Effect of locally generated angiotensin II on noradrenergic neuroeffector function in the rat isolated caudal artery. J HypertensSuppl. 1987;5:S47-S52.
36. Story DF, Ziogas J. Role of the endothelium on the facilitatory effects of angiotensin I and angiotensin II on noradrenergic transmission in the caudal artery of the rat. Br J Pharmacol. 1986;87:249-255.
37. Nakamaru M, Jackson EK, Inagami T. Beta-adrenoceptor-mediated release of angiotensin II from mesenteric arteries. Am J Physiol. 1986;250:H144-H148.
38. Kawasaki H, Cline WH Jr, Su C. Enhanced angiotensin-mediated facilitation of adrenergic neurotransmission in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1982;221:112-116.
39. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52:415-472.
40. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23:38-44.
41. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension. 1998;31:342-348.
42. Gurantz D, Cowling RT, Villarreal FJ, Greenberg BH. Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts. Circ Res. 1999;85:272-279.
43. Iwai N, Izumi M, Inagami T, Kinoshita M. Induction of renin in medial smooth muscle cells by balloon injury. Hypertension. 1997;29:1044-1050.
44. Kifor I, Dzau VJ. Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circ Res. 1987;60:422-428.
45. Re R, Fallon JT, Dzau V, Ouay SC, Haber E. Renin synthesis by canine aortic smooth muscle cells in culture. Life Sci. 1982;30:99-106.
46. Moulds RF, Worland PJ. Potentiation of human vascular smooth muscle contraction by angiotensin. J Cardiovasc Pharmacol. 1980;2:377-386.
47. Muller DN, Bohlender J, Hilgers KF, Dragun D, Costerousse O, Menard J, Luft FC. Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension. 1997;29:98-104.
48. Saijonmaa O, Nyman T, Fyhrquist F. Downregulation of angiotensinconverting enzyme by tumor necrosis factor-alpha and interleukin-1beta in cultured human endothelial cells. J Vasc Res. 2001;38:370-378.
49. Leite R, Estevao R, Resende AC, Salgado MC. Role of endothelium in angiotensin II formation by the rat aorta and mesenteric arterial bed. Braz J Med Biol Res. 1997;30:649-656.
50. Wassmann K, Ghiassi A, Wassmann S, Bohm M, Nickenig G. AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women. Maturitas. 2006;53:176-183.
51. Ito H, Ohshima A, Tsuzuki M, Ohto N, Takao K, Hijii C, Yanagawa M, Ogasawara M, Nishioka K. Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women. Clin Exp Pharmacol Physiol. 2001;28:188-192.
52. Ceresini G, Freddi M, Morganti S, Rebecchi I, Modena AB, Rinaldi M, Manca C, Amaducci A, Del Rio G, Valenti G. The effects of transdermal estradiol on the response to mental stress in postmenopausal women: a randomized trial. Am J Med. 2000;109:463-468.
53. Grassi G. Role of the sympathetic nervous system in human hypertension. J Hypertens. 1998;16:1979-1987.
54. Davrath LR, Goren Y, Pinhas I, Toledo E, Akselrod S. Early autonomic malfunction in normotensive individuals with a genetic predisposition to essential hypertension. Am J Physiol Heart Circ Physiol. 2003;285:H1697-H1704.